These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25185022)
1. Plasma and liver lipid profiles in rats exposed to chronic hypobaric hypoxia: changes in metabolic pathways. Siques P; Brito J; Naveas N; Pulido R; De la Cruz JJ; Mamani M; León-Velarde F High Alt Med Biol; 2014 Sep; 15(3):388-95. PubMed ID: 25185022 [TBL] [Abstract][Full Text] [Related]
2. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Li J; Bosch-Marce M; Nanayakkara A; Savransky V; Fried SK; Semenza GL; Polotsky VY Physiol Genomics; 2006 May; 25(3):450-7. PubMed ID: 16507783 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of triglyceride-lowering effect of an HMG-CoA reductase inhibitor in a hypertriglyceridemic animal model, the Zucker obese rat. Kasim SE; LeBoeuf RC; Khilnani S; Tallapaka L; Dayananda D; Jen KL J Lipid Res; 1992 Jan; 33(1):1-7. PubMed ID: 1552226 [TBL] [Abstract][Full Text] [Related]
4. A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats. Guo J; Bei W; Hu Y; Tang C; He W; Liu X; Huang L; Cao Y; Hu X; Zhong X; Cao L J Ethnopharmacol; 2011 May; 135(2):299-307. PubMed ID: 21396994 [TBL] [Abstract][Full Text] [Related]
5. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion. Van Zuiden PE; Erickson SK; Cooper AD J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151 [TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure. Liang K; Kim CH; Vaziri ND Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547 [TBL] [Abstract][Full Text] [Related]
7. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. König B; Koch A; Spielmann J; Hilgenfeld C; Stangl GI; Eder K Biochem Pharmacol; 2007 Feb; 73(4):574-85. PubMed ID: 17126302 [TBL] [Abstract][Full Text] [Related]
8. In vitro effects of active components of Polygonum Multiflorum Radix on enzymes involved in the lipid metabolism. Wang W; He Y; Lin P; Li Y; Sun R; Gu W; Yu J; Zhao R J Ethnopharmacol; 2014 May; 153(3):763-70. PubMed ID: 24680992 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. Stanely Mainzen Prince P; Kannan NK J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661 [TBL] [Abstract][Full Text] [Related]
10. Hepatic fatty acid metabolism as a determinant of plasma and liver triacylglycerol levels. Studies on tetradecylthioacetic and tetradecylthiopropionic acids. Asiedu DK; al-Shurbaji A; Rustan AC; Björkhem I; Berglund L; Berge RK Eur J Biochem; 1995 Feb; 227(3):715-22. PubMed ID: 7867630 [TBL] [Abstract][Full Text] [Related]